Skip to main content
Top
Published in: Molecular Cancer 1/2010

Open Access 01-12-2010 | Research

Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion

Authors: Stefanie Tauber, Alexander Jais, Markus Jeitler, Sandra Haider, Julia Husa, Josefine Lindroos, Martin Knöfler, Matthias Mayerhofer, Hubert Pehamberger, Oswald Wagner, Martin Bilban

Published in: Molecular Cancer | Issue 1/2010

Login to get access

Abstract

Background

Heme Oxygenase-1 (HO-1) is expressed in many cancers and promotes growth and survival of neoplastic cells. Recently, HO-1 has been implicated in tumor cell invasion and metastasis. However, the molecular mechanisms underlying these biologic effects of HO-1 remain largely unknown. To identify a common mechanism of action of HO-1 in cancer, we determined the global effect of HO-1 on the transcriptome of multiple tumor entities and identified a universal HO-1-associated gene expression signature.

Results

Genome-wide expression profiling of Heme Oxygenase-1 expressing versus HO-1 silenced BeWo choriocarcinoma cells as well as a comparative meta-profiling of the preexisting expression database of 190 human tumors of 14 independent cancer types led to the identification of 14 genes, the expression of which correlated strongly and universally with that of HO-1 (P = 0.00002). These genes included regulators of cell plasticity and extracellular matrix (ECM) remodeling (MMP2, ADAM8, TGFB1, BGN, COL21A1, PXDN), signaling (CRIP2, MICB), amino acid transport and glycosylation (SLC7A1 and ST3GAL2), estrogen and phospholipid biosynthesis (AGPAT2 and HSD17B1), protein stabilization (IFI30), and phosphorylation (ALPPL2). We selected PXDN, an adhesion molecule involved in ECM formation, for further analysis and functional characterization. Immunofluorescence and Western blotting confirmed the positive correlation of expression of PXDN and HO-1 in BeWo cancer cells as well as co-localization of these two proteins in invasive extravillous trophoblast cells. Modulation of HO-1 expression in both loss-of and gain-of function cell models (BeWo and 607B melanoma cells, respectively) demonstrated a direct relationship of HO-1 expression with cell adhesion to Fibronectin and Laminin coated wells. The adhesion-promoting effects of HO-1 were dependent on PXDN expression, as loss of PXDN in HO-1 expressing BeWo and 607B cells led to reduced cell attachment to Laminin and Fibronectin coated wells.

Conclusions

Collectively, our results show that HO-1 expression determines a distinct 'molecular signature' in cancer cells, which is enriched in genes associated with tumorigenesis. The protein network downstream of HO-1 modulates adhesion, signaling, transport, and other critical cellular functions of neoplastic cells and thus promotes tumor cell growth and dissemination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Otterbein LE: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24 (8): 449-55. 10.1016/S1471-4906(03)00181-9CrossRefPubMed Otterbein LE: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24 (8): 449-55. 10.1016/S1471-4906(03)00181-9CrossRefPubMed
2.
go back to reference Bilban M: Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med. 2008, 86 (3): 267-79. 10.1007/s00109-007-0276-0CrossRefPubMed Bilban M: Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med. 2008, 86 (3): 267-79. 10.1007/s00109-007-0276-0CrossRefPubMed
3.
go back to reference Nishie A: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999, 5 (5): 1107-13.PubMed Nishie A: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999, 5 (5): 1107-13.PubMed
4.
go back to reference Liu LG: Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed Environ Sci. 2004, 17 (3): 315-26.PubMed Liu LG: Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed Environ Sci. 2004, 17 (3): 315-26.PubMed
5.
go back to reference Busserolles J: Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol. 2006, 38 (9): 1510-7. 10.1016/j.biocel.2006.03.013CrossRefPubMed Busserolles J: Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol. 2006, 38 (9): 1510-7. 10.1016/j.biocel.2006.03.013CrossRefPubMed
7.
8.
go back to reference Kikuchi A: Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet. 2005, 116 (5): 354-60. 10.1007/s00439-004-1162-2CrossRefPubMed Kikuchi A: Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet. 2005, 116 (5): 354-60. 10.1007/s00439-004-1162-2CrossRefPubMed
9.
go back to reference Okamoto I: A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma. Int J Cancer. 2006, 119 (6): 1312-5. 10.1002/ijc.21937CrossRefPubMed Okamoto I: A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma. Int J Cancer. 2006, 119 (6): 1312-5. 10.1002/ijc.21937CrossRefPubMed
10.
go back to reference Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003, 3 (5): 362-74. 10.1038/nrc1075CrossRefPubMed Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003, 3 (5): 362-74. 10.1038/nrc1075CrossRefPubMed
11.
go back to reference Alexandrova AY: Evolution of cell interactions with extracellular matrix during carcinogenesis. Biochemistry (Mosc). 2008, 73 (7): 733-41. 10.1134/S0006297908070018CrossRef Alexandrova AY: Evolution of cell interactions with extracellular matrix during carcinogenesis. Biochemistry (Mosc). 2008, 73 (7): 733-41. 10.1134/S0006297908070018CrossRef
12.
go back to reference Gueron G: Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009, 7 (11): 1745-55. 10.1158/1541-7786.MCR-08-0325CrossRefPubMed Gueron G: Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009, 7 (11): 1745-55. 10.1158/1541-7786.MCR-08-0325CrossRefPubMed
13.
go back to reference Alaoui-Jamali MA: A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 2009, 69 (20): 8017-24. 10.1158/0008-5472.CAN-09-0419CrossRefPubMed Alaoui-Jamali MA: A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 2009, 69 (20): 8017-24. 10.1158/0008-5472.CAN-09-0419CrossRefPubMed
14.
go back to reference Sunamura M: Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis. 2003, 6 (1): 15-24. 10.1023/A:1025803600840CrossRefPubMed Sunamura M: Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis. 2003, 6 (1): 15-24. 10.1023/A:1025803600840CrossRefPubMed
15.
go back to reference Was H: Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol. 2006, 169 (6): 2181-98. 10.2353/ajpath.2006.051365PubMedCentralCrossRefPubMed Was H: Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol. 2006, 169 (6): 2181-98. 10.2353/ajpath.2006.051365PubMedCentralCrossRefPubMed
17.
go back to reference Mayerhofer M: Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood. 2008, 111 (4): 2200-10. 10.1182/blood-2006-11-055723CrossRefPubMed Mayerhofer M: Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood. 2008, 111 (4): 2200-10. 10.1182/blood-2006-11-055723CrossRefPubMed
18.
go back to reference Forbes K: Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta. 2009, 30 (2): 124-9. 10.1016/j.placenta.2008.10.003PubMedCentralCrossRefPubMed Forbes K: Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta. 2009, 30 (2): 124-9. 10.1016/j.placenta.2008.10.003PubMedCentralCrossRefPubMed
19.
go back to reference Astapova I: The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci USA. 2008, 105 (49): 19544-9. 10.1073/pnas.0804604105PubMedCentralCrossRefPubMed Astapova I: The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci USA. 2008, 105 (49): 19544-9. 10.1073/pnas.0804604105PubMedCentralCrossRefPubMed
20.
go back to reference Subramanian A: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102 (43): 15545-50. 10.1073/pnas.0506580102PubMedCentralCrossRefPubMed Subramanian A: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102 (43): 15545-50. 10.1073/pnas.0506580102PubMedCentralCrossRefPubMed
21.
go back to reference Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3-PubMed Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3-PubMed
22.
go back to reference Ramaswamy S: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001, 98 (26): 15149-54. 10.1073/pnas.211566398PubMedCentralCrossRefPubMed Ramaswamy S: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001, 98 (26): 15149-54. 10.1073/pnas.211566398PubMedCentralCrossRefPubMed
23.
24.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-8. 10.1006/meth.2001.1262CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-8. 10.1006/meth.2001.1262CrossRefPubMed
25.
go back to reference Bilban M: Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology. 2009, 150 (2): 1000-13. 10.1210/en.2008-0456PubMedCentralCrossRefPubMed Bilban M: Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology. 2009, 150 (2): 1000-13. 10.1210/en.2008-0456PubMedCentralCrossRefPubMed
26.
go back to reference Bauer S: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab. 2004, 89 (2): 812-22. 10.1210/jc.2003-031351CrossRefPubMed Bauer S: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab. 2004, 89 (2): 812-22. 10.1210/jc.2003-031351CrossRefPubMed
27.
go back to reference Hintermann E: Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol. 2001, 153 (3): 465-78. 10.1083/jcb.153.3.465PubMedCentralCrossRefPubMed Hintermann E: Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol. 2001, 153 (3): 465-78. 10.1083/jcb.153.3.465PubMedCentralCrossRefPubMed
28.
go back to reference Hayami S: Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer. 9: 59- Hayami S: Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer. 9: 59-
29.
go back to reference Lin Q: Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007, 282 (28): 20621-33. 10.1074/jbc.M607954200CrossRefPubMed Lin Q: Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007, 282 (28): 20621-33. 10.1074/jbc.M607954200CrossRefPubMed
30.
go back to reference Seldon MP: Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J Immunol. 2007, 179 (11): 7840-51.CrossRefPubMed Seldon MP: Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J Immunol. 2007, 179 (11): 7840-51.CrossRefPubMed
31.
go back to reference Kim HP: Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol. 2005, 175 (4): 2622-9.CrossRefPubMed Kim HP: Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol. 2005, 175 (4): 2622-9.CrossRefPubMed
32.
go back to reference Chin BY: Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA. 2007, 104 (12): 5109-14. 10.1073/pnas.0609611104PubMedCentralCrossRefPubMed Chin BY: Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA. 2007, 104 (12): 5109-14. 10.1073/pnas.0609611104PubMedCentralCrossRefPubMed
33.
go back to reference Dioum EM: NPAS2: a gas-responsive transcription factor. Science. 2002, 298 (5602): 2385-7. 10.1126/science.1078456CrossRefPubMed Dioum EM: NPAS2: a gas-responsive transcription factor. Science. 2002, 298 (5602): 2385-7. 10.1126/science.1078456CrossRefPubMed
34.
go back to reference Raghuram S: Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol. 2007, 14 (12): 1207-13. 10.1038/nsmb1344PubMedCentralCrossRefPubMed Raghuram S: Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol. 2007, 14 (12): 1207-13. 10.1038/nsmb1344PubMedCentralCrossRefPubMed
35.
go back to reference Pardee KI: The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta. PLoS Biol. 2009, 7 (2): e43- 10.1371/journal.pbio.1000043CrossRefPubMed Pardee KI: The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta. PLoS Biol. 2009, 7 (2): e43- 10.1371/journal.pbio.1000043CrossRefPubMed
36.
37.
go back to reference Bilban M: DNA microarrays: a novel approach to investigate genomics in trophoblast invasion--a review. Placenta. 2000, 21 (Suppl A): S99-105. 10.1053/plac.1999.0517CrossRefPubMed Bilban M: DNA microarrays: a novel approach to investigate genomics in trophoblast invasion--a review. Placenta. 2000, 21 (Suppl A): S99-105. 10.1053/plac.1999.0517CrossRefPubMed
38.
go back to reference Peterfi Z: Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol. 2009, 175 (2): 725-35. 10.2353/ajpath.2009.080693PubMedCentralCrossRefPubMed Peterfi Z: Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol. 2009, 175 (2): 725-35. 10.2353/ajpath.2009.080693PubMedCentralCrossRefPubMed
39.
go back to reference Mitchell MS: A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res. 2000, 60 (22): 6448-56.PubMed Mitchell MS: A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res. 2000, 60 (22): 6448-56.PubMed
40.
go back to reference Castronovo V: A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics. 2006, 5 (11): 2083-91. 10.1074/mcp.M600164-MCP200CrossRefPubMed Castronovo V: A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics. 2006, 5 (11): 2083-91. 10.1074/mcp.M600164-MCP200CrossRefPubMed
Metadata
Title
Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion
Authors
Stefanie Tauber
Alexander Jais
Markus Jeitler
Sandra Haider
Julia Husa
Josefine Lindroos
Martin Knöfler
Matthias Mayerhofer
Hubert Pehamberger
Oswald Wagner
Martin Bilban
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-9-200

Other articles of this Issue 1/2010

Molecular Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine